Brainsway (BWAY)
(Delayed Data from NSDQ)
$10.00 USD
+0.16 (1.63%)
Updated Nov 22, 2024 04:00 PM ET
After-Market: $9.99 -0.01 (-0.10%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth B Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
BWAY 10.00 +0.16(1.63%)
Will BWAY be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for BWAY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BWAY
Brainsway (BWAY) Is a Great Choice for 'Trend' Investors, Here's Why
Solventum Q3 Earnings Likely to Reflect Declining Volume Trend
BWAY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Strong Demand and Positive Pricing to Drive Baxter's Q3 Earnings
Is Brainsway (BWAY) Stock Outpacing Its Medical Peers This Year?
Strong Segmental Performance to Drive Stryker's Q3 Earnings
Other News for BWAY
BrainsWay’s Deep TMS Shows Promise in Pain Reduction
Brainsway announces publication on pain reduction with Deep TMS therapy
Brainsway announces publication on pain reduction with Deep TMS therapy
BrainsWay: Cash Flow Doubts Weigh On The Stock
Brainsway price target raised to $13.40 from $12.60 at Ladenburg